sdiction. Contacts Media — Foundation Medicine Dan Budwick Pure Communications, Inc. or Investors — Foundation Medicine Matt Clawson, Source: Foundation Medicine, Inc. EFTA00676602 View this news release online at: ;Powered by Business Wire http://v.w.v.businesswire.cominews/home/20130729006496/en EFTA00676603

s CLIA-certified lab. Please visit www.FoundationOne.com for more information. Foundation Medicine@ and FoundationOne@ are registered trademarks of Foundation Medicine, Inc. About Priority Health Priority Health is an award-winning, Michigan-based non-profit health plan nationally recognized for improving the health an

bH Investment Entity Payment Demands Gates, through one or more affiliated entities (the "Gates Purchaser"), has heretofore made an investment in Foundation Medicine, Inc., a Delaware corporation with principal offices located in Cambridge, Massachusetts ("Foundation Medicine"), in the amount of Ten Million Dollars (

r team for all of your efforts. EFTA_R1_00447439 EFTA01967988 Best regards, --Bob Robert W. Hesslein Senior Vice President / General Counsel Foundation Medicine, Inc. This communication and any files transmitted with it may contain information that is considered to be confidential, privileged and exempt from disc

ive September 3, 2013 (the "Letter Agreement"); and WHEREAS, while serving as an observer board member attending meetings the Board of Directors of Foundation Medicine, Inc. ("FMI"), lock-ups and other restrictions on transfer with respect to the securities of FMI which were imposed on members of FMI's Board of Directors

dici ne-persona li zed-cancer- ph=rmaceutical-ipo-fetches-1-billion-valuation?source=email_rt_mc_focus_2> by The Value Investor More News on FMI • Foundation Medicine, Inc. misses by $0.05, beats on revenue <http://emai Iseeki ngal pha .com:80/=rack?type=click&mai lingid=1638353&messageid=CM_2900&=3Bdataba seid=&seri a

likely at one point within next year a reimbursement decision will happened by CMS which will propel to the multiples of it current value. B From: Foundation Medicine, Inc. [mailt Sent: Tuesday, August 12, 2014 1:08 P To: Boris Nikolic Subject: Foundation Medicine Announces 2014 Second Quarter Results and Recent Highl

5 EFTA01961313 - 40 - EFTA_R1_00436126 EFTA01961314 t ( 1 ( -41- EFTA_R1_00436127 EFTA01961315 - 41 - EFTA_R1_00436128 EFTA01961316 Foundation Medicine, Inc. and ResearchGate GmbH - 43 - EFTA_R1_00436129 EFTA01961317 44 EFTA_R1_00436130 EFTA01961318 - 45 - EFTA_R1_00436131 EFTA01961319 - 46 -